Literature DB >> 32752945

Synthesis, characterization, powder X-ray diffraction analysis, thermal stability, antioxidant properties and enzyme inhibitions of M(II)-Schiff base ligand complexes.

Kenan Buldurun1, Nevin Turan1, Ercan Bursal2, Abdulmelik Aras3, Asim Mantarcı4, Naki Çolak5, Fikret Türkan6, İlhami Gülçin7.   

Abstract

The Schiff base ligand ((E)-6-methyl-2-(2,3,4-trimethoxybenzylideneamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile) and its cobalt(II) and palladium(II) complexes were successfully prepared. The structure of the compounds was elucidated by various techniques (NMR, FT-IR, powder X-ray diffraction, microanalysis, TGA, magnetic susceptibility, mass spectrometry). The Pd(II) complex showed a square planar geometry and the Co(II) complex had an octahedral geometry. ABTS (2,2-azino-bis 3-ethylbenzothiazloine-6-sulphonic acid), DPPH (1,1-diphenyl-2-picrylhydrazyl), FRAP (ferric-reducing antioxidant power) and CUPRAC (cupric reducing antioxidant capacity) in vitro methods were applied to identify the antioxidant features of the synthesized compounds. In addition, glutathione S-transferase and acetyl/butyryl cholinesterase enzymes were examined for possible inhibition capacities of the complexes. According to the enzyme activity measurements, Ru(II) complex inhibited both GST and BChE enzymes, while Fe(II) complex inhibited only AChE enzyme. Furthermore, the antioxidant activities and enzyme inhibitions of the previously synthesized Fe(II) and Ru(II) complexes of the same ligand were examined to make a comparison of the metal complexes.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  Metal complex; Schiff base; antioxidant activity; enzyme inhibition; spectroscopic techniques

Year:  2020        PMID: 32752945     DOI: 10.1080/07391102.2020.1802340

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Synthesis, characterization, antioxidant and anticancer activities of a new Schiff base and its M(II) complexes derived from 5-fluorouracil.

Authors:  Ahmet Savcı; Kenan Buldurun; Mehmet Eşref Alkış; Yusuf Alan; Nevin Turan
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

2.  Antioxidant, Antidiabetic, Anticholinergic, and Antiglaucoma Effects of Magnofluorine.

Authors:  Lokman Durmaz; Hatice Kiziltas; Leyla Guven; Hasan Karagecili; Saleh Alwasel; İlhami Gulcin
Journal:  Molecules       Date:  2022-09-11       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.